capital · May 16, 2026

Profound Medical Holders Back Board, Auditor, and LTIP in Shareholder Vote

Profound Medical Corp. shareholders approved director elections and an increase in board size at the May 13, 2026 annual meeting. The vote confirmed eight directors to serve until the next annual meeting. Support for the long-term incentive plan resolution reached 63.922% in favor. The company operates in the medical devices sector with executives including CEO Arun Menawat, CFO Rashed Dewan, President Mathieu Burtnyk, and Chief Commercial Officer Tom Tamberrino. No new funding or product details emerged from the meeting results.